MMWR Recomm Rep. 1999 Oct 1;48(RR-12):1-37.
Routine vaccination of children is the most effective way to reduce hepatitis A incidence nationwide over time. Since licensure of hepatitis A vaccine in 1995, this strategy has been implemented incrementally, starting with the recommendation of the Advisory Committee on Immunization Practices (ACIP) in 1996 to vaccinate children living in communities with the highest rates of infection and disease. These updated recommendations represent the next phase of this hepatitis A immunization strategy. Vaccination of children living in states and communities with consistently elevated rates of hepatitis A will provide protection from disease and is expected to reduce the overall incidence of hepatitis A. This report updates the ACIP's 1996 recommendations on the prevention of hepatitis A through immunization (MMWR 1996;45:[No. RR-151) and includes a) new data about the epidemiology of hepatitis A; b) recent findings about the effectiveness of community-based hepatitis A vaccination programs; and c) recommendations for the routine vaccination of children in states, counties, and communities with rates that are twice the 1987-1997 national average or greater (i.e., > or = 20 cases per 100,000 population) and consideration of routine vaccination of children in states, counties, and communities with rates exceeding the 1987-1997 national average (i.e., > or = 10 but <20 cases per 100,000 population). Unchanged in this report are previous recommendations regarding the vaccination of persons in groups at increased risk for hepatitis A or its adverse consequences and recommendations regarding the use of immune globulin for protection against hepatitis A.
随着时间的推移,儿童常规疫苗接种是降低全国甲型肝炎发病率的最有效方法。自1995年甲型肝炎疫苗获得许可以来,这一策略已逐步实施,始于1996年免疫实践咨询委员会(ACIP)建议为感染率和发病率最高社区的儿童接种疫苗。这些更新后的建议代表了甲型肝炎免疫策略的下一阶段。为甲型肝炎发病率持续升高的州和社区的儿童接种疫苗将预防疾病,并有望降低甲型肝炎的总体发病率。本报告更新了ACIP 1996年关于通过免疫预防甲型肝炎的建议(《发病率与死亡率周报》1996年;45:[第RR - 15号]),并包括:a)关于甲型肝炎流行病学的新数据;b)关于基于社区的甲型肝炎疫苗接种项目有效性的近期研究结果;以及c)针对甲型肝炎发病率是1987 - 1997年全国平均水平两倍或更高(即每10万人中≥20例)的州、县和社区儿童常规接种疫苗的建议,以及对甲型肝炎发病率超过1987 - 1997年全国平均水平(即每10万人中≥10例但<20例)的州、县和社区儿童常规接种疫苗的考虑。本报告中关于甲型肝炎或其不良后果风险增加人群的疫苗接种以及关于使用免疫球蛋白预防甲型肝炎的先前建议未作更改。